ASCO Guidelines

Podcast autorstwa American Society of Clinical Oncology (ASCO)

180 Odcinki

Medically Integrated Dispensing Pharmacy: ASCO-NCODA Standards Update
Opublikowany: 27.05.2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Guideline
Opublikowany: 9.05.2025
Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Guideline Update
Opublikowany: 2.05.2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Rapid Update
Opublikowany: 29.04.2025
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Guideline Update
Opublikowany: 10.04.2025
Fertility Preservation in People with Cancer Guideline Update
Opublikowany: 19.03.2025
Opioid Conversion in Adults with Cancer: MASCC-ASCO-AAHPM-HPNA-NICSO Guideline
Opublikowany: 5.03.2025
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.3 Part 2
Opublikowany: 27.02.2025
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2024.3 Part 1
Opublikowany: 27.02.2025
TORS in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma Guideline
Opublikowany: 11.02.2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer Guideline Update
Opublikowany: 22.01.2025
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer Guideline
Opublikowany: 9.01.2025
Treatment of Pleural Mesothelioma Update
Opublikowany: 8.01.2025
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma Guideline
Opublikowany: 16.12.2024
Systemic Therapy for SCLC Rapid Update
Opublikowany: 20.11.2024
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.2
Opublikowany: 12.11.2024
Management of Locally Advanced Rectal Cancer Guideline
Opublikowany: 8.08.2024
Management of Stage III NSCLC Rapid Update
Opublikowany: 23.07.2024
Selection of Germline Genetic Testing Panels in Patients with Cancer Guideline
Opublikowany: 20.06.2024
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.1
Opublikowany: 30.05.2024

1 / 9

Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.

Visit the podcast's native language site

180 Odcinki

Medically Integrated Dispensing Pharmacy: ASCO-NCODA Standards Update

Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Guideline

Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Guideline Update

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Rapid Update

Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Guideline Update

Fertility Preservation in People with Cancer Guideline Update

Opioid Conversion in Adults with Cancer: MASCC-ASCO-AAHPM-HPNA-NICSO Guideline

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.3 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2024.3 Part 1

TORS in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma Guideline

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer Guideline Update

Germline and Somatic Genomic Testing for Metastatic Prostate Cancer Guideline

Treatment of Pleural Mesothelioma Update

Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma Guideline

Systemic Therapy for SCLC Rapid Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.2

Management of Locally Advanced Rectal Cancer Guideline

Management of Stage III NSCLC Rapid Update

Selection of Germline Genetic Testing Panels in Patients with Cancer Guideline

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.1